Vetter breaks ground on $285m US clinical manufacturing site
German contract development and manufacturing organisation Vetter Pharma has commenced construction of a new $285m clinical manufacturing facility in Des…
Other Diseases
-
-
BioCity’s SC0062 gains NMPA breakthrough therapy designation
The Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted BioCity's endothelin receptor type A…
-
Navamedic signs agreement to acquire dne pharma
Navamedic has signed an agreement for the acquisition of Norwegian company dne pharma in a Nkr225m ($22m) deal. This acquisition…
-
Aytu BioPharma to commercialise Exxua for MDD in the US
Aytu BioPharma has signed an exclusive agreement with Fabre-Kramer Pharmaceuticals to commercialise Exxua (gepirone) extended-release tablets, a new antidepressant, to…
-
Rare disease treatments skipping UK patients largely due to costs, survey shows
UK patients living with rare diseases are not being offered many of the life-changing medicines being developed, mainly due to…
-
Emergent to donate 20,000 Narcan doses to fight opioid overdoses, CEO says
Emergent BioSolutions has pledged to donate 20,000 doses of Narcan nasal spray (naloxone) to communities affected by opioid overdoses. Emergent…
-
SK pharmteco announces $260m production expansion in South Korea
SK pharmteco, a contract development and manufacturing organisation, has announced an investment of $260m to expand its small molecule and…
-
MaxCyte and Kamau Therapeutics sign platform license agreement
MaxCyte, a company specialising in cell engineering technologies, has entered a strategic platform licence (SPL) agreement with Kamau Therapeutics, a…
-
Attralus set for amyloidosis asset’s European orphan designations
The European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) has given positive opinions for the awarding of an…
-
AstraZeneca champions early kidney disease diagnosis with modelling data
AstraZeneca has highlighted both the economic and environmental benefits of implementing early, targeted screening for chronic kidney disease (CKD). CKD…
